Piper Jaffray Companies initiated coverage on shares of OrthoPediatrics Corp. (NASDAQ:KIDS) in a report issued on Monday, November 6th, MarketBeat reports. The brokerage issued an overweight rating and a $24.00 target price on the stock.
Shares of OrthoPediatrics (KIDS) traded up $0.02 during trading hours on Monday, hitting $20.39. 9,926 shares of the stock were exchanged, compared to its average volume of 44,736. OrthoPediatrics has a 1-year low of $17.03 and a 1-year high of $23.00.
In other OrthoPediatrics news, Director Harold Ruf bought 11,500 shares of OrthoPediatrics stock in a transaction dated Monday, October 16th. The stock was acquired at an average cost of $13.00 per share, with a total value of $149,500.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.
Receive News & Ratings for OrthoPediatrics Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics Corp. and related companies with our FREE daily email newsletter.